Addyi was 1st authorised via the FDA in August 2015 to treat hypoactive sexual wish dysfunction (HSDD) in premenopausal Gals. Which is just yet another way of claiming it boosts sexual intercourse push (also known as libido) in women who've not attained menopause. It was the initial this sort of drug accredited for this use. Intended to guidance